Cargando…
Inhibition of atypical protein kinase C-ι effectively reduces the malignancy of prostate cancer cells by downregulating the NF-κB signaling cascade
Prostate cancer (PC) is the most common type of cancer among men. Aggressive and metastatic PC results in life- threatening tumors, and represents one of the leading causes of mortality in men. Previous studies of atypical protein kinase C isoforms (aPKCs) have highlighted its role in the survival o...
Autores principales: | Apostolatos, André H., Ratnayake, Wishrawana S., Win-Piazza, Hla, Apostolatos, Christopher A., Smalley, Tracess, kang, Loveleen, Salup, Raoul, Hill, Robert, Acevedo-Duncan, Mildred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192717/ https://www.ncbi.nlm.nih.gov/pubmed/30226591 http://dx.doi.org/10.3892/ijo.2018.4542 |
Ejemplares similares
-
Oncogenic PKC-ι activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC-ι and PKC-ζ specific inhibitors
por: Ratnayake, Wishrawana S., et al.
Publicado: (2018) -
Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C-ι inhibitor as a potential prostate carcinoma therapeutic
por: Apostolatos, André H., et al.
Publicado: (2019) -
Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis
por: Ratnayake, Wishrawana S., et al.
Publicado: (2017) -
Analysis of PKC-ζ protein levels in normal and malignant breast tissue subtypes
por: Smalley, Tracess, et al.
Publicado: (2019) -
Atypical PKCs activate Vimentin to facilitate prostate cancer cell motility and invasion
por: Ratnayake, Wishrawana S., et al.
Publicado: (2021)